Overview

Treatment of Schizoaffective Disorder Using Mifepristone

Status:
Terminated
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
This study tests the hypothesis that mifepristone will diminish cognitive distortion and alleviate psychosis in patients with schizoaffective disorder.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
Stanford University
Collaborator:
Pritzker Family Foundation
Treatments:
Mifepristone